Repositorio Dspace

Colchicine for secondary prevention of ischaemic stroke and atherosclerotic events: a meta-analysis of randomised trials

Mostrar el registro sencillo del ítem

dc.contributor.author Fiolet, Aernoud-TL
dc.contributor.author Poorthuis, Michiel-HF
dc.contributor.author Opstal, Tjerk-SJ
dc.contributor.author Amarenco, Pierre
dc.contributor.author Boczar, Kevin-Emery
dc.contributor.author Buysschaert, Ian
dc.contributor.author Budgeon, Charley
dc.contributor.author Chan, Noel-C
dc.contributor.author Cornel, Jan-H
dc.contributor.author Jolly, Sanjit-S
dc.contributor.author Layland, Jamie
dc.contributor.author Lemmens, Robin
dc.contributor.author Mewton, Nathan
dc.contributor.author Nidorf, Stefan-M
dc.contributor.author Pascual-Figal, Domingo-A
dc.contributor.author Price, Christopher
dc.contributor.author Shah, Binita
dc.contributor.author Tardif, Jean-Claude
dc.contributor.author Thompson, Peter-L
dc.contributor.author Tijssen, Jan-GP
dc.contributor.author Tsivgoulis, Georgios
dc.contributor.author Walsh, Cathal
dc.contributor.author Wang, Yongjun
dc.contributor.author Weimar, Christian
dc.contributor.author Eikelboom, John-W
dc.contributor.author Mosterd, Arend
dc.contributor.author Kelly, Peter-J
dc.date.accessioned 2025-12-03T11:11:52Z
dc.date.available 2025-12-03T11:11:52Z
dc.date.issued 2024-10
dc.identifier.citation Fiolet ATL, Poorthuis MHF, Opstal TSJ, Amarenco P, Boczar KE, Buysschaert I, et al. Colchicine for secondary prevention of ischaemic stroke and atherosclerotic events: a meta-analysis of randomised trials. eClinicalMedicine. octubre de 2024;76:102835.
dc.identifier.uri https://sms.carm.es/ricsmur/handle/123456789/22950
dc.description.abstract BACKGROUND: Guidelines recommend low-dose colchicine for secondary prevention in cardiovascular disease, but uncertainty remains concerning its efficacy for stroke, efficacy in key subgroups and about uncommon but serious safety outcomes. METHODS: In this trial-level meta-analysis, we searched bibliographic databases and trial registries form inception to May 16, 2024. We included randomised trials of colchicine for secondary prevention of ischaemic stroke and major adverse cardiovascular events (MACE: ischaemic stroke, myocardial infarction, coronary revascularisation, or cardiovascular death). Secondary outcomes were serious safety outcomes and mortality. A fixed-effect inverse-variance model was used to generate a pooled estimate of relative risk (RR) with 95% confidence intervals (CI). This study is registered with PROSPERO, CRD42024540320. FINDINGS: Six trials involving 14,934 patients with prior stroke or coronary disease were included. In all patients, colchicine compared with placebo or no colchicine reduced the risk for ischaemic stroke by 27% (132 [1.8%] events versus 186 [2.5%] events, RR 0.73 [95% CI 0.58-0.90]) and MACE by 27% (505 [6.8%] events versus 693 [9.4%] events, with RR 0.73 [0.65-0.81]). Efficacy was consistent in key subgroups (females versus males, age below versus above 70, with versus without diabetes, statin versus non-statin users). Colchicine was not associated with an increase in serious safety outcomes: hospitalisation for pneumonia (109 [1.5%] versus 106 [1.5%], RR 0.99 [0.76-1.30]), cancer (247 [3.5%] versus 255 [3.6%], RR 0.97 [0.82-1.15]), and gastro-intestinal events (153 [2.1%] versus 135 [1.9%]), RR 1.15 [0.91-1.44]. There was no difference in all-cause death (201 [2.7%] versus 181 [2.4%], RR 1.09 [0.89-1.33]), cardiovascular death (70 [0.9%] versus 80 [1.1%], RR 0.89 [0.65-1.23]), or non-cardiovascular death (131 [1.8%] versus 101 [1.4%], RR 1.26 [0.98-1.64]). INTERPRETATION: In patients with prior stroke or coronary disease, colchicine reduced ischaemic stroke and MACE, with consistent treatment effect in key subgroups, and did not increase serious safety events or death. FUNDING: There was no funding source for this study.
dc.language.iso eng
dc.publisher ELSEVIER
dc.rights Atribución/Reconocimiento-NoComercial-SinDerivados 4.0 Internacional 
dc.rights.uri https://creativecommons.org/licenses/by-nc-nd/4.0 * 
dc.title Colchicine for secondary prevention of ischaemic stroke and atherosclerotic events: a meta-analysis of randomised trials
dc.type info:eu-repo/semantics/article
dc.identifier.pmid 39431112
dc.relation.publisherversion https://linkinghub.elsevier.com/retrieve/pii/S2589537024004140
dc.identifier.doi 10.1016/j.eclinm.2024.102835
dc.journal.title Eclinicalmedicine
dc.identifier.essn 2589-5370


Ficheros en el ítem

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Atribución/Reconocimiento-NoComercial-SinDerivados 4.0 Internacional  Excepto si se señala otra cosa, la licencia del ítem se describe como Atribución/Reconocimiento-NoComercial-SinDerivados 4.0 Internacional 

Buscar en DSpace


Búsqueda avanzada

Listar

Mi cuenta